Back to Jane Street Group, LLC Jane Street Group, LLC

VKTXVKTX

Showing 8 of 30 quarters

Position history for Jane Street Group, LLCJane Street Group, LLC's holdings in Viking Therapeutics, Inc.

Yes. Jane Street Group holds 899,558 shares of VKTX (Viking Therapeutics), worth $35.1M, as of its Q2 2026 13F filing. It increased the position by 150,609 shares (+20.1%) from Q1 2026. Jane Street Group has held VKTX since Q3 2021, across 20 quarterly 13F filings.

Current Value

$35.1M

Current Shares

899,558

Total Value Change

+$13.6M

Total Shares Change

+560,751

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
899,558
+20.1%
$35.1M0.0%$39.01
34
2026-Q1
Decreased
748,949
-50.1%
$24.4M0.0%$32.54
0
2025-Q4
Increased
1.5M
+89.1%
$52.8M0.0%$35.18
46
2025-Q3
Increased
793,806
+8.4%
$20.9M0.0%$26.28
31
2025-Q2
Increased
732,174
+292.3%
$19.4M0.0%$26.50
46
2025-Q1
Decreased
186,646
-54.2%
$4.5M0.0%$24.15
0
2024-Q4
Increased
407,679
+20.3%
$16.4M0.0%$40.24
34
2024-Q3
Decreased
338,807
-11.6%
$21.4M0.0%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used